(Hypertension. 1999;34:31-38.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Laboratório de Genética e Cardiologia Molecular e Dept Clínica Médica/LIM 13, Instituto do Coração, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Correspondence to Dr Jose Eduardo Krieger, Laboratório de Genética e Cardiologia Molecular, Instituto do Coração, Faculdade de Medicina da Universidade de São Paulo, Ave Dr Eneas C. Aguiar 44 SP, Brazil CEP 05403-000. E-mail krieger{at}incor.usp.br
AbstractTo shed light on mechanisms of angiotensin-converting enzyme (ACE) upregulation, we used a rabbit endothelial cell model to characterize intracellular pathways of ß-adrenergic stimulation. In these cells, ACE activity is increased by isoproterenol (ISO). The stably transfected 1273-bp ACE promoter is stimulated by ISO in the presence of isobutyl methylxanthine. This effect is abolished by propranolol. Promoter stimulation is mimicked by cholera toxin, forskolin, and 8BrcAMP, but not by 8BrcGMP. Promoter stimulation by ISO and isobutyl methylxanthine is blocked by protein kinase A inhibitors, indicating that ß-adrenergic stimulation of the ACE gene depends on phosphorylation of protein kinase A targets. Activation by cAMP, resistance to phorbol ester, and lack of synergism between cAMP and phorbol ester suggest that promoter regulation is due to cAMP responsive element rather than to activating protein-2 sequences. Okadaic acid potentiation of 8BrcAMP induction indicated that promoter activation by cAMP is regulated by phosphatases controlling activation of typical cAMP responsive element regulated genes. In summary, ß-adrenergic activation of rat ACE promoter is specific; uses Gs proteins, adenylyl cyclase, protein kinase A; and probably includes cAMP responsive elementlike sequences.
Key Words: angiotensin-converting enzyme endothelium receptors, adrenergic, beta cyclic AMP luciferase
This article has been cited by other articles:
![]() |
G. J Dietze and E. J Henriksen Review: Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis Journal of Renin-Angiotensin-Aldosterone System, June 1, 2008; 9(2): 75 - 88. [Abstract] [PDF] |
||||
![]() |
A. C. Solal, G. Jondeau, F. Beauvais, and A. Berdeaux Beneficial effects of carvedilol on angiotensin-converting enzyme activity and renin plasma levels in patients with chronic heart failure Eur J Heart Fail, June 1, 2004; 6(4): 463 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Freshour, S. E. Chase, and K. L. Vikstrom Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1997 - H2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. M. Barreto-Chaves, I. Aneas, and J. E. Krieger Glucocorticoid regulation of angiotensin-converting enzyme in primary culture of adult cardiac fibroblasts Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2001; 280(1): R25 - R32. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |